[1] Centers for Disease Control and Prevention, “Measles — United States, January 1–April 17, 2025,” MMWR Morb. Mortal. Wkly. Rep., vol. 74, no. 14, 2025. [Online]. Available: https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm
[2] A. Johnson, S. Penmetsa, and A. Nazir, “Measles resurgence in the United States: epidemiological and clinical observations from 2025,” Int. J. Surg., vol. 112, no. 1, pp. 2110–2111, Jan. 2026, doi: 10.1097/JS9.0000000000003499.
[3] Pan American Health Organization, “Update on the review of measles elimination status,” PAHO, Washington, DC, USA, Mar. 2, 2026. [Online]. Available: https://www.paho.org/en/news/2-3-2026-update-review-measles-elimination-status
[4] Centers for Disease Control and Prevention, “Clinical Overview of Measles,” CDC, reviewed Nov. 24, 2025. [Online]. Available: https://www.cdc.gov/measles/hcp/clinical-overview/index.html
[5] W. J. Moss, “Measles,” The Lancet, vol. 390, no. 10111, pp. 2490–2502, Dec. 2017, doi: 10.1016/S0140-6736(17)31463-0.
[6] J. M. Hübschen, I. Gouandjika-Vasilache, and J. Dina, “Measles,” The Lancet, vol. 399, no. 10325, pp. 678–690, Feb. 2022, doi: 10.1016/S0140-6736(21)02004-3.
[7] “Measles (n.),” Online Etymology Dictionary. [Online]. Available: https://www.etymonline.com/word/measles (Non-clinical/linguistic source — see Accuracy Note G.)
[8] World Health Organization, “Measles,” WHO Fact Sheet, Nov. 28, 2025. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/measles
[9] Centers for Disease Control and Prevention, “How Measles Spreads,” CDC, Apr. 2026. [Online]. Available: https://www.cdc.gov/measles/causes/index.html
[10] I. M. Tahir, V. Kumar, H. Faisal, A. Gill, V. Kumari, H. M. Tahir, and M. A. Haque, “Contagion comeback: unravelling the measles outbreak across the USA,” Front. Public Health, vol. 12, art. 1491927, Dec. 2024, doi: 10.3389/fpubh.2024.1491927.
[11] A. A. Minta, M. Ferrari, S. Antoni, et al., “Progress toward measles elimination — worldwide, 2000–2022,” MMWR Morb. Mortal. Wkly. Rep., vol. 72, no. 46, pp. 1262–1268, Nov. 2023, doi: 10.15585/mmwr.mm7246a3.
[12] M. J. Mina, T. Kula, Y. Leng, M. Li, R. D. de Vries, M. Knip, et al., “Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens,” Science, vol. 366, no. 6465, pp. 599–606, Nov. 2019, doi: 10.1126/science.aay6485.
[13] V. N. Petrova, B. Sawatsky, A. X. Han, B. M. Laksono, L. Walz, E. Parker, et al., “Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles,” Sci. Immunol., vol. 4, no. 41, art. eaay6125, Nov. 2019, doi: 10.1126/sciimmunol.aay6125.
[14] M. J. Mina, C. J. E. Metcalf, R. L. de Swart, A. D. M. E. Osterhaus, and B. T. Grenfell, “Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality,” Science, vol. 348, no. 6235, pp. 694–699, May 2015, doi: 10.1126/science.aaa3662.
[15] Centers for Disease Control and Prevention, “Measles Clinical Diagnosis Fact Sheet,” CDC, May 2025. [Online]. Available: https://www.cdc.gov/measles/hcp/communication-resources/clinical-diagnosis-fact-sheet.html
[16] Centers for Disease Control and Prevention, “Chapter 13: Measles,” in Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book), CDC. [Online]. Available: https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
[17] J. Goodson and T. Filardo, “Measles (Rubeola),” in CDC Yellow Book 2026: Health Information for International Travel, E. Halsey, Ed. Oxford, U.K.: Oxford Univ. Press, 2025. [Online]. Available: https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/measles-rubeola.html
[18] American Academy of Pediatrics, “Measles,” in Red Book: 2024–2027 Report of the Committee on Infectious Diseases, 33rd ed. Itasca, IL, USA: American Academy of Pediatrics, 2024.